Pradaxa Antidote Does Not Eliminate Bleeding Risks
Pradaxa Antidote, Praxbind, Only Available in Hospitals. The bleeding risks associated with Pradaxa (dabigatran etexilate) are fairly well known in the United States following a number of serious injury reports and deaths. Pradaxa was approved by the U.S. Food and Drug Administration (FDA) in 2010 and is manufactured by drug maker … [Read more...] about Pradaxa Antidote Does Not Eliminate Bleeding Risks
Pradaxa Patients Face Bleeding Risks Despite Antidote
Pradaxa Patients Face Bleeding Risks Despite Antidote. The bleeding risk for people taking the blood-thinning drug Pradaxa is well documented, and the risk persists despite a recently developed bleeding antidote. Many patients allege that the drug maker was reckless in introducing Pradaxa to the market with a bleeding … [Read more...] about Pradaxa Patients Face Bleeding Risks Despite Antidote
